Biobeat
24 Hour Cuff-less Blood Pressure Monitoring
Startup A Health Tech & Life Sciences Est. 2016
Total Raised
$18.6M
A
Last Round
$7M
6 rounds
Investors
5
5 public
Team
6
11-50 employees
Confidence
100/100
News
22
articles
Patents
1
About
Biobeat is a med-tech company providing FDA-cleared, cuffless blood pressure monitoring. The small, non-invasive sensor is placed onto the patient’s chest for 24 hours, and the measurements are taken through our proprietary patented PPG sensor. The technology not only allows for blood pressure to be taken, but also extracts heart rate, and cardiac output. The device and automated platform deliver a detailed report to the clinician, immediately after the patient has completed the test. This allows for quick evaluation and treatment plans, and also enables physicians to make proper adjustments on current treatment plans based on the quantitative measures and trends that the blood pressure monitoring solution provides. The Biobeat sensor eliminates white coat and masked hypertension by using a cuffless test. White coat hypertension is a common barrier in ABPM testing, as patients often become stressed when the cuff inflates. However, with Biobeat, patients often forget they are wearing the sensor and do not feel when the readings are being taken. This allows them to go about their daily lives without interruption.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Core Technology
Semiconductors & ElectronicsWearablesArtificial IntelligenceMachine LearningSensingBiometrics
Target Customer
Healthcare & Life SciencesLife SciencesMedical Devices IndustryHealthcareProviders
Business Model
B2BB2B2C
Tags
clinical-trialsearly-detectionmonitoringwearablesensorsdecision-supportmedical-technologiesinsurance-companiesmobile-applicationsdiagnosticsreal-timephysiological-parametersmeasurementsseniorstreatmentspharma-companiespersonalizationmachine-learningweb-platformalert-system
Funding & Events
Sep 2023
A Round $7M
Best Buy Health
Nov 2017
Seed $2M
Undisclosed Investor(s), Co-Share
Mar 2020
A Round $8M
Menomadin Foundation
Jun 2016
Seed $1M
Undisclosed Investor(s)
Feb 2021
Undisclosed Round Undisclosed
Infinity Medical
Dec 2018
Non-equity $600K
DRIVe
News (22)
Mar 13, 2024 · www.news4jax.com
growth-positive
Toss the cuff: A new blood pressure patch is here
Customers
Dec 31, 2023 · www.bio-beat.com
growth-positive
Tampa General launches hospital at-home program
CustomersPartners
Sep 6, 2022 · www.prnewswire.com
growth-positive
Biobeat joins Innovators' Network at American Heart Association Center for Health Technology & Innovation
Partners
Mar 28, 2022 · www.massdevice.com
growth-positive
FDA clears Biobeat's remote vital sign monitoring system
CustomersPartners
May 4, 2021 · www.prnewswire.com
growth-positive
Biobeat's AI-Powered Remote Patient Monitoring Platform Receives A Full CE Mark
CustomersPartners
growth-positive
Biobeat to Trial Patient Monitoring Devices with Acute Ischemic Stroke Patients -
CustomersPartners
Jan 19, 2021 · www.prnewswire.com
growth-positive
Biobeat Launches Health AI Hospital At Home Patient Monitoring Kit
CustomersPartners
Dec 22, 2020 · www.unite.ai
growth-positive
Arik Ben Ishay, CEO of Biobeat - Interview Series - Unite.AI
CustomersPartners
Dec 21, 2020 · www.fiercebiotech.com
N/A
https://www.fiercebiotech.com/special-report/biobeat-fierce-medtech-s-top-10-m-a-targets-for-2020
Oct 27, 2020 · infomeddnews.com
growth-positive
Biobeat Wearable Wrist And Chest Patient Monitoring Solutions Receives Class II Medical Device Approval From Health Canada - Medical Device News Magazine
CustomersPartners
Oct 7, 2020 · www.jpost.com
growth-positive
https://www.jpost.com/health-science/blood-pressure-can-be-meaused-simply-with-biobeats-cuffless-solution-644874
Customers
Oct 5, 2020 · www.prnewswire.com
growth-positive
Clinical Study Highlights Accuracy of Biobeat's Wearable Cuffless Blood Pressure Monitoring Device When Compared To Traditional Cuff-Based Devices
Customers
Apr 27, 2020 · www.jpost.com
growth-positive
https://www.jpost.com/opinion/petach-tikvah-firm-develops-wireless-medical-monitoring-system-622545
CustomersPartners
Mar 11, 2020 · www.prnewswire.com
growth-positive
The Groundbreaking Biobeat Monitoring Platform Provides an Ideal Solution in Caring for Coronavirus Patients
CustomersPartners
Mar 4, 2020 · www.jpost.com
growth-positive
https://www.jpost.com/Israel-News/Coronavirus-facility-opens-at-Rambam-Hospital-using-new-Israeli-tech-619681
Expand
Feb 18, 2020 · www.prnewswire.co.uk
growth-positive
The Biobeat Wearable Wristwatch and Patch Receive CE Mark Approval for Non-invasive Cuffless Monitoring of Blood Pressure, as Well as Cardiac Output, Stroke Volume, Pulse and Saturation
CustomersPartners
growth-positive
BioBeat's Cuffless Blood Pressure Monitoring Device, USA
CustomersPartnersInvestment
Aug 26, 2019 · en.globes.co.il
growth-positive
FDA approves Israeli co Biobeat's patch and watch
CustomersPartners
Mar 1, 2019 · www.jpost.com
growth-positive
https://www.jpost.com/Jpost-Tech/Business-and-Innovation/Hillels-Tech-Corner-582108
CustomersInvestment
Jan 3, 2019 · healthtechinsider.com
growth-positive
Wearable Suite Tracks Vitals for Alerts and Trends
CustomersExpand
+ 2 more articles
Details
Product Stage
Released
Employees
11-50
Exact Count
43
District
Center District
Founded
2016
Registrar
515356418
Crunchbase
biobeat
Locations
Ef'al St 22, Petah Tikva, Israel
Florida, USA
Links
Website
LinkedIn
Twitter
Careers
Admin
Last Update
Jan 2, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (6)
Gilad Glick
Chairman of the Board
Dr. Meirav Galili
Board Member
Arik Ben Ishay
CEO
Founder
Johanan May
Co-founder & CTO
Founder
Israel Sarussi
Co-founder & VP R&D
Founder
Liat Amosy
Marketing Manager
Internal
Created by
Benjamin Futoriansky (ben.futor@gmail.com)
Created
2016-06-06T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)